project id: TCGA-CESC; case submitter id: TCGA-C5-A1MH; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.7; spectrophotometer method: UV Spec; age at index: 71; days to birth: -26234; days to death: 1186; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1933; year of death: 2007; age at diagnosis: 26234; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; is ffpe: false; composition: Not Reported; days to collection: 2417; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-C5-A1MH-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;